Polpharma Finished Dosage Formulation Dossier - Under Development - Pharmaceutical Technology

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

DOWNLOAD WHITEPAPER

Polpharma Finished Dosage Formulation Dossier – Under Development

This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development. Products listed include Esomeprazole powder for the treatment of peptic ulcers and gastro-oesophageal reflux disease, Orlistat anti-obesity capsules, Sitagliptin film-coated tablets for reducing blood glucose, and the Aciclovir antiviral tablets for systemic use. Download this brochure to find out more.

Download to find out more.

DOWNLOAD
Email*

Submit

DOWNLOAD WHITEPAPER

Polpharma Finished Dosage Formulation Dossier – Under Development

This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development. Products listed include Esomeprazole powder for the treatment of peptic ulcers and gastro-oesophageal reflux disease, Orlistat anti-obesity capsules, Sitagliptin film-coated tablets for reducing blood glucose, and the Aciclovir antiviral tablets for systemic use. Download this brochure to find out more.

Download to find out more.

DOWNLOAD

We just need a few more details

Name* Company* Job Title*

I have read and accept the terms and conditions and privacy policys.

We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.

If you would like to hear from carefully selected third party companies, check this box

Follow this company to receive notifications when they update.